Target intelligence / Profile preview

Corneal epithelial regeneration pathways (null)

Target
null
Molecular classification
Other (not a single molecule or receptor; refers to multiple signaling and cellular pathways)
01

Overview

Corneal epithelial regeneration pathways" is not the name of a single molecule, receptor, enzyme, or druggable protein. Instead, it refers collectively to the complex network of cellular processes and molecular signaling cascades that govern the renewal and repair of the corneal epithelium. The primary drivers are limbal stem cells (LSCs), which reside at the corneoscleral junction ("limbus") and give rise to transient amplifying cells that proliferate and differentiate into mature corneal epithelial layers. Key regulatory signals include Wnt and Notch signaling for proliferation/differentiation balance; SPARC has been identified as an adaptive regeneration marker upregulated during wound healing. Disruption in these regenerative processes—such as from LSCD—leads to vision loss due to failure of normal surface maintenance. Current therapeutic strategies focus on transplantation/expansion of LSCs using various culture systems; modulation of key signaling networks is under investigation for improving outcomes. Because this entry describes broad biological processes rather than a discrete molecular entity, it should not be considered a canonical therapeutic target but rather an area encompassing multiple potential targets within its component molecules/pathways.

Other names
Corneal epithelial renewal pathwaysCorneal epithelium regenerative mechanismsLimbal stem cell (LSC) differentiation and renewal pathways
02

Mechanism of action

null

03

Biological functions

Cell proliferationCell differentiationTissue regenerationWound healingBarrier function maintenance
04

Disease associations

Blindness (corneal blindness)Limbal stem cell deficiency (LSCD)Dry eye diseaseDiabetes-related corneal dysfunction
05

Safety considerations

Immune rejection of allogeneic limbal stem cell transplantsInefficient expansion of LSCs in xenobiotic-free systems leading to poor graft survival ratesPotential for abnormal differentiation or tumorigenesis with engineered cells or gene therapy approaches
06

Biomarkers

SPARC (as an adaptive regeneration marker)Limbal stem cell markers such as ABCG2, p63α, CK15Other gene expression signatures identified by scRNAseq in LSCs and differentiating cells

Beyond the preview

Go deeper on Corneal epithelial regeneration pathways (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal epithelial regeneration pathways (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call